The adiponectin receptor agonist AdipoAI attenuates periodontitis in diabetic rats by inhibiting gingival fibroblast-induced macrophage migration.
Wei QiuZhaodan WangZehao ChenQian SunHongle WuZhao ChenKaiqi LuanZining LiuDian DingQisheng TuJake ChenBuling WuFuchun FangPublished in: British journal of pharmacology (2023)
AdipoAI, with its ability to alleviate inflammatory damage in tissues, is a candidate for diabetes-associated periodontitis treatment.